Accendra Health Inc (ACH) Key Metrics
ACH valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $18.1M
- Enterprise value
- $1.83B
- P/E (TTM)
- — 10-yr median 19.8
- Forward P/E
- 6.9
- PEG ratio
- 0.70
- Price / sales
- 0.0 10-yr median 0.1
- Price / book
- 1.1 10-yr median 1.6
- EV / EBITDA
- 6.9 10-yr median 9.9
- Dividend yield
- —
- Beta
- 1.57
ACH key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsACH valuation Price multiples at each fiscal year-end price.
Price / sales−16.8%
0.1
2025 · hover or tap a bar for each year
20162025
EV / EBITDA−83.7%
9.9
2025 · hover or tap a bar for each year
20162025
Free cash flow yield−134.1 pts
−140.8%
2025 · hover or tap a bar for each year
20162025
ACH returns How much profit the business earns on the capital it uses.
Return on invested capital+14.2 pts
8.4%
2025 · hover or tap a bar for each year
20162025
Return on assets−23.5 pts
−31.0%
2025 · hover or tap a bar for each year
20162025
Free cash flow margin−10.4 pts
−11.0%
2025 · hover or tap a bar for each year
20162025
Asset turnover−64.6%
0.78
2025 · hover or tap a bar for each year
20162025
ACH per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−74.2%
$35.92
2025 · hover or tap a bar for each year
20162025
Earnings per share
−$14.31
2025 · hover or tap a bar for each year
20162025
Free cash flow per share
−$3.94
2025 · hover or tap a bar for each year
20162025
Book value per share
−$5.99
2025 · hover or tap a bar for each year
20162025
Shares outstanding+0.2%
76.9M
2025 · hover or tap a bar for each year
20162025
ACH financial health Debt, liquidity and how easily interest is covered.
Net debt−$138.6M
$1.95B
2025 · hover or tap a bar for each year
20162025
Net debt / EBITDA−31.93
8.88
2025 · hover or tap a bar for each year
20162025
Current ratio−46.4%
0.58
2025 · hover or tap a bar for each year
20162025
Interest coverage
2.1
2025 · hover or tap a bar for each year
20162025
Debt / assets+98.3%
0.91
2025 · hover or tap a bar for each year
20162025
ACH efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+30 days
52 days
2025 · hover or tap a bar for each year
20162025
Days of inventory+101 days
149 days
2025 · hover or tap a bar for each year
20162025
Days payables outstanding+148 days
200 days
2025 · hover or tap a bar for each year
20162025
Cash conversion cycle−17 days
1 days
2025 · hover or tap a bar for each year
20162025
Capex / revenue+5.2 pts
7.3%
2025 · hover or tap a bar for each year
20162025
ACH valuation history
Fiscal year-endToday10-year median
ACH returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
ACH debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
ACH cash returned to shareholders
DividendsBuybacksFree cash flow
ACH price vs earnings per share
Share price at year-endEPS (right axis)
ACH key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $215.3M | $1.00B | $1.46B | $1.49B | $3.28B | $1.72B | $313.2M | $379.9M | $1.13B | $2.16B |
| Enterprise value | $2.17B | $3.09B | $3.62B | $4.21B | $4.38B | $2.74B | $1.95B | $1.96B | $1.93B | $2.54B |
| P/E ratio | — | — | — | 66.5 | 14.8 | 57.5 | — | — | 15.6 | 19.8 |
| Price / sales | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.2 | 0.0 | 0.0 | 0.1 | 0.2 |
| Price / book | — | 1.8 | 1.6 | 1.6 | 3.5 | 2.4 | 0.7 | 0.7 | 1.1 | 2.2 |
| Price / free cash flow | — | — | 2.7 | 9.4 | 44.1 | 6.1 | 2.8 | 7.6 | 187.6 | 13.7 |
| Price / operating cash flow | — | 6.2 | 2.0 | 4.6 | 26.4 | 5.1 | 1.9 | 3.3 | 20.0 | 11.5 |
| EV / sales | 0.8 | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 |
| EV / EBITDA | 9.9 | 60.4 | 9.3 | 11.4 | 10.5 | 8.5 | 10.5 | — | 9.2 | 9.1 |
| EV / free cash flow | — | — | 6.8 | 26.6 | 58.8 | 9.8 | 17.2 | 39.4 | 319.5 | 16.2 |
| Earnings yield | −511.2% | −36.2% | −2.8% | 1.5% | 6.7% | 1.7% | −19.9% | −115.0% | 6.4% | 5.0% |
| Free cash flow yield | −140.8% | −6.6% | 36.5% | 10.6% | 2.3% | 16.3% | 36.4% | 13.1% | 0.5% | 7.3% |
| Dividend yield | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 1.7% | 12.7% | 5.6% | 2.9% |
| Shareholder yield (dividends + buybacks) | 4.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.7% | 12.7% | 6.0% | 6.2% |
| Share price at fiscal year-end | $2.80 | $13.07 | $19.27 | $19.53 | $43.50 | $27.05 | $5.17 | $6.33 | $18.88 | $35.29 |
| Per share | ||||||||||
| Revenue per share | $35.92 | $139.44 | $136.36 | $130.62 | $129.63 | $133.52 | $152.06 | $156.93 | $155.30 | $159.16 |
| Earnings per share | −$14.31 | −$4.73 | −$0.54 | $0.29 | $2.94 | $0.47 | −$1.03 | −$7.28 | $1.21 | $1.78 |
| Operating cash flow per share | −$1.32 | $2.10 | $9.77 | $4.26 | $1.65 | $5.34 | $2.74 | $1.93 | $0.95 | $3.06 |
| Free cash flow per share | −$3.94 | −$0.87 | $7.03 | $2.08 | $0.99 | $4.41 | $1.88 | $0.83 | $0.10 | $2.57 |
| Cash per share | $3.67 | $0.64 | $3.21 | $0.91 | $0.74 | $1.86 | $1.11 | $1.10 | $1.74 | $3.04 |
| Book value per share | −$5.99 | $7.37 | $12.19 | $12.41 | $12.43 | $11.21 | $7.63 | $8.64 | $16.92 | $15.71 |
| Tangible book value per share | −$23.74 | −$13.85 | −$14.20 | −$15.41 | $4.03 | $0.58 | −$3.57 | −$3.62 | $1.95 | $7.57 |
| Dividends per share | — | — | $0.00 | $0.00 | $0.01 | $0.01 | $0.09 | $0.80 | $1.05 | $1.04 |
| Capex per share | $2.62 | $2.97 | $2.74 | $2.19 | $0.66 | $0.93 | $0.86 | $1.09 | $0.85 | $0.49 |
| Debt per share | $29.05 | $27.88 | $31.74 | $36.65 | $15.28 | $17.96 | $28.20 | $27.50 | $15.01 | $9.24 |
| Shares outstanding | 76.9M | 76.7M | 75.8M | 76.2M | 75.5M | 63.5M | 60.6M | 60.0M | 60.0M | 61.1M |
| Change in shares outstanding | +0.2% | +1.3% | −0.6% | +1.0% | +18.9% | +4.9% | +0.9% | +0.0% | −1.8% | −1.6% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | — | −48.7% | −4.4% | 2.4% | 26.9% | 5.1% | −12.7% | −57.0% | 7.4% | 11.1% |
| Return on invested capital (ROIC) | 8.4% | −5.7% | 2.4% | 5.0% | 15.6% | 8.5% | 2.7% | −14.2% | 5.7% | 9.2% |
| Return on assets (ROA) | −31.0% | −7.4% | −0.8% | 0.5% | 6.4% | 0.9% | −1.7% | −12.2% | 2.4% | 4.0% |
| Return on tangible assets | −101.2% | −12.0% | −1.3% | 0.7% | 7.6% | 1.1% | −2.1% | −14.4% | 2.9% | 4.9% |
| Free cash flow margin | −11.0% | −0.6% | 5.2% | 1.6% | 0.8% | 3.3% | 1.2% | 0.5% | 0.1% | 1.6% |
| Income quality (OCF / net income) | — | — | — | 14.52 | 0.56 | 11.36 | — | — | 0.78 | 1.72 |
| Financial health | ||||||||||
| Total debt | $2.23B | $2.14B | $2.41B | $2.79B | $1.15B | $1.14B | $1.71B | $1.65B | $900.7M | $564.6M |
| Cash & short-term investments | $282.0M | $49.4M | $243.0M | $69.5M | $55.7M | $118.2M | $67.0M | $66.3M | $104.5M | $185.5M |
| Net debt | $1.95B | $2.09B | $2.16B | $2.72B | $1.10B | $1.02B | $1.64B | $1.58B | $796.2M | $379.1M |
| Debt / equity | — | 3.79 | 2.60 | 2.95 | 1.23 | 1.60 | 3.70 | 3.18 | 0.89 | 0.59 |
| Debt / assets | 0.91 | 0.46 | 0.47 | 0.52 | 0.33 | 0.34 | 0.47 | 0.44 | 0.27 | 0.21 |
| Net debt / EBITDA | 8.88 | 40.81 | 5.54 | 7.39 | 2.64 | 3.16 | 8.79 | — | 3.80 | 1.36 |
| Current ratio | 0.58 | 1.08 | 1.11 | 1.47 | 1.73 | 1.59 | 1.70 | 1.72 | 1.67 | 1.90 |
| Quick ratio | 0.50 | 0.47 | 0.52 | 0.61 | 0.61 | 0.67 | 0.89 | 0.85 | 0.91 | 1.01 |
| Interest coverage | 2.1 | -1.4 | 0.7 | 1.1 | 7.7 | 2.4 | 0.7 | -5.0 | 2.8 | 7.4 |
| Working capital | −$399.2M | $147.3M | $210.9M | $728.7M | $977.8M | $790.1M | $991.1M | $1.07B | $872.2M | $927.4M |
| Invested capital | $1.49B | $2.66B | $3.09B | $3.67B | $2.04B | $1.73B | $2.10B | $2.10B | $1.81B | $1.34B |
| Tangible asset value | −$1.83B | −$1.06B | −$1.08B | −$1.17B | $304.6M | $36.6M | −$216.0M | −$217.5M | $117.2M | $462.6M |
| Net current asset value | −$2.36B | −$2.07B | −$2.07B | −$2.15B | −$276.2M | −$487.7M | −$773.6M | −$716.8M | −$178.9M | $204.3M |
| Graham number | — | — | — | $9.06 | $28.66 | $10.89 | — | — | $21.49 | $25.09 |
| Graham net-net per share | −$32.79 | −$38.54 | −$38.56 | −$41.09 | −$17.00 | −$21.46 | −$33.59 | −$32.93 | −$19.87 | −$10.80 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | $0 | $0 | $731,000 | $648,000 | $5.2M | $48.2M | $63.2M | $63.4M |
| Share buybacks (net) | $10.2M | $0 | $0 | $0 | — | — | — | — | $5.0M | $71.0M |
| Dividend payout ratio | — | — | — | 0.0% | 0.3% | 2.2% | — | — | 86.8% | 58.3% |
| Dividends + buybacks / free cash flow | — | — | 0.0% | 0.0% | 1.0% | 0.2% | 4.6% | 96.6% | — | 85.7% |
| Capex / revenue | 7.3% | 2.1% | 2.0% | 1.7% | 0.5% | 0.7% | 0.6% | 0.7% | 0.5% | 0.3% |
| Capex / operating cash flow | — | 141.3% | 28.1% | 51.3% | 40.0% | 17.4% | 31.4% | 56.8% | 89.4% | 16.1% |
| Capex / depreciation | 0.94 | 0.86 | 0.72 | 0.73 | 0.55 | 0.63 | 0.45 | 0.64 | 0.85 | 0.54 |
| Stock-based compensation / revenue | 0.5% | 0.3% | 0.2% | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% |
| R&D / revenue | — | — | — | — | 0.1% | — | — | — | — | — |
| SG&A / revenue | 38.7% | 17.8% | 17.5% | 15.6% | 11.0% | 12.3% | 11.1% | 13.4% | 10.9% | 10.0% |
| Efficiency | ||||||||||
| Days sales outstanding | 51.9 | 22.0 | 24.0 | 26.5 | 25.8 | 29.6 | 28.4 | 29.4 | 26.7 | 22.4 |
| Days of inventory on hand | 149.5 | 48.3 | 54.3 | 63.5 | 60.2 | 60.3 | 55.0 | 49.9 | 42.7 | 39.7 |
| Days payables outstanding | 200.2 | 52.2 | 51.6 | 48.3 | 44.2 | 45.8 | 42.3 | 44.0 | 38.0 | 31.2 |
| Cash conversion cycle (days) | 1.2 | 18.1 | 26.8 | 41.8 | 41.8 | 44.1 | 41.1 | 35.2 | 31.4 | 30.9 |
| Receivables turnover | 7.03 | 16.61 | 15.18 | 13.78 | 14.16 | 12.33 | 12.87 | 12.43 | 13.65 | 16.29 |
| Payables turnover | 1.82 | 7.00 | 7.08 | 7.56 | 8.26 | 7.96 | 8.63 | 8.29 | 9.59 | 11.68 |
| Inventory turnover | 2.44 | 7.56 | 6.72 | 5.75 | 6.06 | 6.05 | 6.64 | 7.32 | 8.55 | 9.19 |
| Asset turnover | 0.78 | 2.20 | 1.97 | 2.23 | 2.85 | 2.43 | 2.48 | 2.63 | 3.06 | 3.54 |
| Average receivables | $393.1M | $644.2M | $680.9M | $722.5M | $691.2M | $687.7M | $715.7M | $757.8M | $682.5M | $597.0M |
| Average payables | $807.8M | $1.21B | $1.16B | $1.07B | $1.00B | $904.1M | $936.6M | $1.01B | $849.2M | $730.7M |
| Average inventory | $603.2M | $1.12B | $1.22B | $1.41B | $1.36B | $1.19B | $1.22B | $1.14B | $953.3M | $928.5M |
| Intangibles / total assets | 55.7% | 35.0% | 39.3% | 39.4% | 17.9% | 20.2% | 18.6% | 19.5% | 26.6% | 18.3% |
Computed from ACH's annual financial statements (latest annual report filed February 20, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
ACH valuation and financial ratios
Accendra Health earned a return on invested capital of 8.4% in fiscal 2025. It ended the year with $2.2 billion of debt and $282.0 million in cash and short-term investments, net debt of $2.0 billion. It returned $10.2 million to shareholders: $0 in dividends and $10.2 million in share buybacks. The share count rose 25.9% from 61.1M to 76.9M over 9 years.
See the ACH income statement, the ACH chart for price history, or the ACH stock overview for the latest quote and news.
ACH key metrics FAQ
What is Accendra Health's EV/EBITDA?
Accendra Health's enterprise value was 9.9 times EBITDA at the end of fiscal 2025 (enterprise value $2.2 billion, EBITDA $219.8 million); the current EV/EBITDA is 6.9.
What is Accendra Health's ROIC?
Accendra Health's return on invested capital was 8.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Accendra Health have?
Accendra Health had total debt of $2.2 billion at the end of fiscal 2025 and $2.0 billion of net debt (8.88 times EBITDA).
Does Accendra Health buy back its shares?
Yes. Accendra Health spent $10.2 million on net share repurchases in fiscal 2025 Shares outstanding changed +0.2% over the year, to 76.9M..
What is Accendra Health's free cash flow yield?
Accendra Health generated -$303.1 million of free cash flow in fiscal 2025, a free cash flow yield of −140.8% on its market value at year-end ($215.3 million).
What is Accendra Health's current ratio?
Accendra Health's current ratio was 0.58 at the end of fiscal 2025: current assets were 0.58 times current liabilities.